Omeros (OMER) Total Debt Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.91% |
| Dec 31, 2025 | -21.95% |
| Sep 30, 2025 | -20.90% |
| Jun 30, 2025 | -11.78% |
| Mar 31, 2025 | -9.55% |
| Dec 31, 2024 | -10.54% |
| Sep 30, 2024 | -9.91% |
| Jun 30, 2024 | -9.24% |
| Mar 31, 2024 | 6.78% |
| Dec 31, 2023 | 7.30% |
| Sep 30, 2023 | 19.09% |
| Jun 30, 2023 | 19.39% |
| Mar 31, 2023 | 29.85% |
| Dec 31, 2022 | 30.35% |
| Sep 30, 2022 | 30.51% |
| Jun 30, 2022 | 30.91% |
| Mar 31, 2022 | 31.21% |
| Dec 31, 2021 | 31.50% |
| Sep 30, 2021 | 34.74% |
| Jun 30, 2021 | 34.88% |
| Mar 31, 2021 | 44.21% |
| Dec 31, 2020 | 36.51% |
| Sep 30, 2020 | 52.15% |
| Jun 30, 2020 | 39.64% |
| Mar 31, 2020 | 37.32% |
| Dec 31, 2019 | 37.28% |
| Sep 30, 2019 | 36.78% |
| Jun 30, 2019 | 36.50% |
| Mar 31, 2019 | 36.70% |
| Dec 31, 2018 | 48.87% |
| Sep 30, 2018 | 45.34% |
| Jun 30, 2018 | 45.06% |
| Mar 31, 2018 | 33.47% |
| Dec 31, 2017 | 33.04% |
| Sep 30, 2017 | 57.14% |
| Jun 30, 2017 | 51.20% |
| Mar 31, 2017 | 46.49% |
| Dec 31, 2016 | 32.60% |
| Sep 30, 2016 | 36.10% |
| Jun 30, 2016 | 33.37% |
| Dec 31, 2015 | 38.28% |